Modulation of muscarinic-receptor expression in human embryonic lung fibroblasts by platelet-derived growth factor

Biochem J. 1990 Sep 1;270(2):409-12. doi: 10.1042/bj2700409.

Abstract

Platelet-derived growth factor (PDGF) is known to have regulatory control of a large number of cellular components, including various receptors. We show that muscarinic acetylcholine receptors of the m2 subtype on CCL 137 human fibroblasts in culture are affected by PDGF treatment. A time-dependent down-regulation is observed in steady-state RNA levels, followed by a decrease in ligand-binding capacity. Minimum RNA levels are attained at 11 h; minimum binding capacity is observed after 24 h of treatment. To our knowledge, this is the first example of negative gene control by PDGF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Down-Regulation
  • Embryo, Mammalian
  • Fibroblasts / metabolism*
  • Gene Expression Regulation / drug effects*
  • Humans
  • Kinetics
  • Lung
  • Nucleic Acid Hybridization
  • Platelet-Derived Growth Factor / pharmacology*
  • Quinuclidinyl Benzilate / metabolism
  • RNA, Messenger / metabolism
  • Receptors, Muscarinic / genetics*

Substances

  • Platelet-Derived Growth Factor
  • RNA, Messenger
  • Receptors, Muscarinic
  • Quinuclidinyl Benzilate